AstraZeneca Unit Ducks Patent Fraud, Not Sham Suit Claims
By Bryan Koenig · December 19, 2025, 6:48 PM EST
A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that allegedly...
To view the full article, register now.